{"id":"https://openalex.org/W2072408136","doi":"https://doi.org/10.1016/j.jalz.2010.05.1637","title":"P3\u2010140: Decreased caregiver burden among carers of patients with Parkinson's disease psychosis treated with pimavanserin, a selective 5\u2010HT2A antagonist","display_name":"P3\u2010140: Decreased caregiver burden among carers of patients with Parkinson's disease psychosis treated with pimavanserin, a selective 5\u2010HT2A antagonist","publication_year":2010,"publication_date":"2010-07-01","ids":{"openalex":"https://openalex.org/W2072408136","doi":"https://doi.org/10.1016/j.jalz.2010.05.1637","mag":"2072408136"},"language":"en","primary_location":{"id":"doi:10.1016/j.jalz.2010.05.1637","doi":"https://doi.org/10.1016/j.jalz.2010.05.1637","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.jalz.2010.05.1637","pdf_url":null,"source":{"id":"https://openalex.org/S108427512","display_name":"Alzheimer s & Dementia","issn_l":"1552-5260","issn":["1552-5260","1552-5279"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-3","ki-jl-3","medline","norway-1","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Alzheimer's &amp; Dementia","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5104349049","display_name":"Hilde Williams","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I125377440","display_name":"Acadia Pharmaceuticals (United States)","ror":"https://ror.org/030bhbq32","country_code":"US","type":"company","lineage":["https://openalex.org/I125377440"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Hilde Williams","raw_affiliation_strings":["Acadia Pharmaceuticals, Inc., San Diego, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Acadia Pharmaceuticals, Inc., San Diego, CA, USA","institution_ids":["https://openalex.org/I125377440"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048160715","display_name":"Daun Bahr","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I125377440","display_name":"Acadia Pharmaceuticals (United States)","ror":"https://ror.org/030bhbq32","country_code":"US","type":"company","lineage":["https://openalex.org/I125377440"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Daun Bahr","raw_affiliation_strings":["Acadia Pharmaceuticals, Inc., San Diego, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Acadia Pharmaceuticals, Inc., San Diego, CA, USA","institution_ids":["https://openalex.org/I125377440"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036730872","display_name":"Perry Peters","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I125377440","display_name":"Acadia Pharmaceuticals (United States)","ror":"https://ror.org/030bhbq32","country_code":"US","type":"company","lineage":["https://openalex.org/I125377440"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Perry Peters","raw_affiliation_strings":["Acadia Pharmaceuticals, Inc., San Diego, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Acadia Pharmaceuticals, Inc., San Diego, CA, USA","institution_ids":["https://openalex.org/I125377440"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5003930471","display_name":"Roger Mills","orcid":"https://orcid.org/0000-0002-3993-4180","observed_orcids":["https://orcid.org/0000-0002-3993-4180"]},"institutions":[{"id":"https://openalex.org/I125377440","display_name":"Acadia Pharmaceuticals (United States)","ror":"https://ror.org/030bhbq32","country_code":"US","type":"company","lineage":["https://openalex.org/I125377440"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Roger Mills","raw_affiliation_strings":["Acadia Pharmaceuticals, Inc., San Diego, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Acadia Pharmaceuticals, Inc., San Diego, CA, USA","institution_ids":["https://openalex.org/I125377440"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I125377440"],"apc_list":{"value":4200,"currency":"USD","value_usd":4200},"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.16455255,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"6","issue":"4S_Part_16","first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10085","display_name":"Parkinson's Disease Mechanisms and Treatments","score":0.9413999915122986,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10085","display_name":"Parkinson's Disease Mechanisms and Treatments","score":0.9413999915122986,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12980","display_name":"Family Caregiving in Mental Illness","score":0.019200000911951065,"subfield":{"id":"https://openalex.org/subfields/3203","display_name":"Clinical Psychology"},"field":{"id":"https://openalex.org/fields/32","display_name":"Psychology"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T13111","display_name":"Nursing care and research","score":0.009499999694526196,"subfield":{"id":"https://openalex.org/subfields/2922","display_name":"Research and Theory"},"field":{"id":"https://openalex.org/fields/29","display_name":"Nursing"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/pimavanserin","display_name":"pimavanserin","score":0.9990000128746033},{"id":"https://openalex.org/keywords/parkinson-s-disease-psychosis","display_name":"Parkinson's disease psychosis","score":0.9980000257492065}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.72125643491745},{"id":"https://openalex.org/C2780494398","wikidata":"https://www.wikidata.org/wiki/Q208144","display_name":"Antipsychotic","level":3,"score":0.7098320126533508},{"id":"https://openalex.org/C2779727114","wikidata":"https://www.wikidata.org/wiki/Q170082","display_name":"Psychosis","level":2,"score":0.6563896536827087},{"id":"https://openalex.org/C2779878486","wikidata":"https://www.wikidata.org/wiki/Q25053589","display_name":"Caregiver burden","level":4,"score":0.6343294382095337},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.6332111358642578},{"id":"https://openalex.org/C2776814716","wikidata":"https://www.wikidata.org/wiki/Q574801","display_name":"Sedation","level":2,"score":0.5071511268615723},{"id":"https://openalex.org/C2776885963","wikidata":"https://www.wikidata.org/wiki/Q245204","display_name":"Antagonist","level":3,"score":0.4865495264530182},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4509819746017456},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.40946200489997864},{"id":"https://openalex.org/C2776412080","wikidata":"https://www.wikidata.org/wiki/Q7431605","display_name":"Schizophrenia (object-oriented programming)","level":2,"score":0.3915329575538635},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.3856527805328369},{"id":"https://openalex.org/C2779483572","wikidata":"https://www.wikidata.org/wiki/Q83030","display_name":"Dementia","level":3,"score":0.21566161513328552},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.20652934908866882},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.0},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1016/j.jalz.2010.05.1637","doi":"https://doi.org/10.1016/j.jalz.2010.05.1637","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.jalz.2010.05.1637","pdf_url":null,"source":{"id":"https://openalex.org/S108427512","display_name":"Alzheimer s & Dementia","issn_l":"1552-5260","issn":["1552-5260","1552-5279"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-3","ki-jl-3","medline","norway-1","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Alzheimer's &amp; Dementia","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W772862339","https://openalex.org/W1965174391","https://openalex.org/W2333444689","https://openalex.org/W2056703646","https://openalex.org/W2039107091","https://openalex.org/W3181433083","https://openalex.org/W4389460210","https://openalex.org/W2107881620","https://openalex.org/W4389447114","https://openalex.org/W6980681353"],"abstract_inverted_index":{"Pimavanserin":[0,301],"is":[1,37,44,68],"a":[2,243],"selective":[3],"5-HT2A":[4],"antagonist":[5],"being":[6],"developed":[7],"for":[8,98,183,212,265],"the":[9,119,142,156,184,207,213,230,238,266],"treatment":[10,144,211,240,302],"of":[11,27,40,123,148,210,246,253,297,303,313,321,329],"Parkinson's":[12],"disease":[13,18],"psychosis":[14,19,298],"(PDP)":[15],"and":[16,35,43,58,61,83,95,121,165,172,181,189,299,319],"Alzheimer's":[17],"(ADP),":[20],"as":[21,23],"well":[22],"schizophrenia.":[24],"The":[25,280],"onset":[26],"psychotic":[28],"symptoms":[29],"in":[30,128,161,201,206,229,284,289,315,324],"elderly":[31],"patients":[32,100,130,255,304],"with":[33,46,74,131,305],"PD":[34],"AD":[36],"an":[38,75],"indicator":[39],"poor":[41],"prognosis":[42],"associated":[45],"increased":[47,59],"caregiver":[48,202,227,281,310,322],"burden,":[49],"more":[50],"rapid":[51],"functional":[52],"decline,":[53],"premature":[54],"nursing":[55],"home":[56],"placement,":[57],"morbidity":[60],"mortality.":[62],"Based":[63],"on":[64,106,166,295],"its":[65],"pharmacology,":[66],"pimavanserin":[67,124,216,269,314],"expected":[69],"to":[70,80,117,136,154,235,242,291,308],"impart":[71],"antipsychotic":[72],"benefit":[73],"improved":[76,96],"safety":[77,120],"profile":[78],"compared":[79],"available":[81],"antipsychotics":[82],"may":[84,101,327],"also":[85],"improve":[86],"nighttime":[87],"sleep":[88,97],"without":[89],"causing":[90],"daytime":[91],"sedation.":[92],"Antipsychotic":[93],"efficacy":[94,122],"these":[99,325],"translate":[102],"into":[103],"reduced":[104],"burden":[105,203,228,323],"their":[107,149],"caregivers.":[108],"An":[109],"international":[110],"Phase":[111],"III":[112],"placebo-controlled":[113],"study":[114,139,286],"was":[115,204],"conducted":[116],"evaluate":[118],"(10,":[125],"40":[126,190,214],"mg)":[127],"298":[129],"PDP.":[132],"Caregivers":[133],"were":[134,152,179,271,287],"required":[135],"attend":[137],"all":[138],"visits":[140],"over":[141,237],"6-week":[143,239],"period.":[145],"As":[146],"part":[147],"participation,":[150],"caregivers":[151],"asked":[153],"complete":[155],"Caregiver":[157],"Burden":[158],"Scale":[159],"(CBS)":[160],"clinic":[162],"at":[163,277],"Baseline":[164],"Visit":[167],"Days":[168],"8,":[169],"15,":[170],"29":[171],"42.":[173],"Mean":[174],"baseline":[175],"(pretreatment)":[176],"CBS":[177,263],"scores":[178,250,264],"30.8":[180],"31.0":[182],"placebo":[185,219,276],"(N":[186,194],"=":[187,195,224],"97)":[188],"mg":[191,215,268],"dose":[192,232],"groups":[193],"92),":[196],"respectively.":[197],"Statistically":[198],"significant":[199],"improvement":[200],"observed":[205],"first":[208],"week":[209],"group":[217,233,270],"vs.":[218,221],"(-3.0":[220],"-1.0;":[222],"p":[223],"0.042).":[225],"Although":[226],"40-mg":[231],"continued":[234],"decrease":[236],"period,":[241],"maximum":[244],"change":[245,257],"-3.7":[247],"points,":[248],"decreased":[249],"among":[251],"carers":[252],"placebo-treated":[254],"(maximum":[256],"-2.4":[258],"points)":[259],"compromised":[260],"statistical":[261],"separation.":[262],"10":[267],"not":[272],"significantly":[273],"different":[274],"from":[275],"any":[278],"timepoint.":[279],"response":[282,293],"curves":[283,294],"this":[285],"similar":[288],"shape":[290],"patient":[292],"measures":[296],"sleep.":[300],"PDP":[306],"appears":[307],"reduce":[309],"burden.":[311],"Studies":[312],"ADP":[316],"are":[317],"planned":[318],"evaluation":[320],"studies":[326],"be":[328],"interest.":[330]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}
